Phenotypic and Metabolic Variations in High-Risk Clones of Multidrug-Resistant Pseudomonas aeruginosa

Sonia J Gutierrez1, Juan David Escobar Prieto2, Deninson Alejandro Vargas3,4

  • 1Biology Department, Faculty of Natural and Exact Sciences, Universidad del Valle, Cali 760031, Colombia.

Microorganisms
|March 28, 2026
PubMed

Insights

High-risk clones (HRCs) of multidrug-resistant Pseudomonas aeruginosa show reduced motility and distinct metabolic profiles, aiding their spread. Understanding these traits is key for infection control against these persistent bacterial strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • The global rise of high-risk clones (HRCs) of multidrug-resistant (MDR) *Pseudomonas aeruginosa* poses significant challenges to infection control and treatment.
  • Globally significant HRCs, such as ST235 and ST111, are prevalent in Colombia, necessitating further investigation into their characteristics.

Purpose of the Study:

  • To investigate the phenotypic and metabolic variations in *P. aeruginosa* isolates, focusing on differences between HRCs and other strains.
  • To understand how these variations contribute to intracellular survival and dissemination in clinical settings.

Main Methods:

  • Collected and categorized 100 clinical *P. aeruginosa* isolates from Colombian hospitals into HRCs (ST235, ST111), multidrug-resistant non-high-risk clones (NHRCs), and susceptible strains (SSs).
  • Evaluated phenotypic traits: motility (swarming, swimming, twitching), spontaneous mutation frequency, biofilm formation, and pigment production (pyocyanin, pyoverdine).
  • Conducted in vitro intracellular survival assays and metabolomic profiling using liquid chromatography-mass spectrometry on a subset of 30 isolates.

Main Results:

  • HRC isolates demonstrated significantly reduced motility (swarming, swimming, twitching) compared to NHRC and SS isolates.
  • HRCs exhibited lower production of pigments pyocyanin and pyoverdine.
  • Metabolomic analysis revealed elevated levels of metabolites related to iron acquisition and siderophore pathways in HRCs, suggesting enhanced iron-scavenging capabilities.

Conclusions:

  • *P. aeruginosa* HRCs possess distinct phenotypic and metabolic characteristics, including reduced motility and altered pigment production.
  • Metabolic profiling indicates a potential advantage in iron acquisition for HRCs, possibly contributing to their persistence.
  • These identified traits likely play a crucial role in the epidemiological success and dissemination of *P. aeruginosa* HRCs in healthcare environments.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
95
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
875
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
155